“ Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? ” (2011) Clinics, 66(7), pp. 1171–1175. doi:10.1590/S1807-59322011000700008.